XML 31 R5.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2019
Mar. 31, 2019
ASSETS    
Cash and cash equivalents $ 2,664 $ 2,198
Restricted cash and cash equivalents 941 985
Investments in marketable securities 3,452 2,908
Finance receivables, net 72,988 70,517
Investments in operating leases, net 37,687 37,927
Other assets 2,206 1,981
Total assets 119,938 116,516
LIABILITIES AND SHAREHOLDER’S EQUITY    
Debt 95,093 92,922
Deferred income taxes 5,594 5,452
Other liabilities 4,840 4,564
Total liabilities 105,527 102,938
Commitments and contingencies (Refer to Note 9)
Shareholder’s equity:    
Capital stock, no par value (100,000 shares authorized; 91,500 issued and outstanding) at September 30, 2019 and March 31, 2019 915 915
Additional paid-in capital 2 2
Accumulated other comprehensive income 18 3
Retained earnings 13,476 12,658
Total shareholder's equity 14,411 13,578
Total liabilities and shareholder's equity $ 119,938 $ 116,516